研究报告

复合益生元组合缓解小鼠特应性皮炎并恢复肠道菌群失调

  • 喻喜华 ,
  • 王一 ,
  • 李刘若兰 ,
  • 陈喜生 ,
  • 王宁 ,
  • 王鸿超
展开
  • 1(国药控股星鲨制药(厦门)有限公司,福建 厦门,361026)
    2(厦门市母婴健康营养产品重点实验室,福建 厦门,361026)
    3(江南大学 食品学院,江苏 无锡,214000)
第一作者:硕士,高级工程师(王鸿超副研究员为通信作者,E-mail:hcwang@jiangnan.edu.cn)

收稿日期: 2025-03-12

  修回日期: 2025-07-14

  网络出版日期: 2026-03-25

A designed prebiotic mixture alleviates atopic dermatitis and restores intestinal dysbiosis in mice

  • YU Xihua ,
  • WANG Yi ,
  • LI Liuruolan ,
  • CHEN Xisheng ,
  • WANG Ning ,
  • WANG Hongchao
Expand
  • 1(Sinopharm Xingsha Pharmaceuticals (Xiamen) Co.Ltd., Xiamen 361026, China)
    2(Xiamen Key Laboratory of Maternal and Infant Health and Nutrition Products, Xiamen 361026, China)
    3(School of Food Science and Technology, Jiangnan University, Wuxi 214000, China)

Received date: 2025-03-12

  Revised date: 2025-07-14

  Online published: 2026-03-25

摘要

特应性皮炎(atopic dermatitis,AD)是一种普遍的过敏性皮肤疾病。该研究基于前期文献调研,选择了具有免疫调节作用的多种益生元,包括低聚果糖、低聚半乳糖、低聚木糖和菊粉,旨在探究单个益生元及其组合对AD症状的缓解效果。结果显示益生元干预缓解了AD小鼠皮肤病理症状,并伴随着过敏炎症相关的效应细胞浸润减少,血清免疫球蛋白E和皮肤组织中IL-4、IL-5、IL-13和胸腺基质淋巴生成素等炎症因子水平的降低,IFN-γ水平的升高。在所有组别中,4种益生元的组合的施用比单一益生元的施用显示出更优异的效果。此外,通过对小鼠肠道菌群进行测序分析发现,益生元组合改变了肠道菌群结构,提高了菌群多样性,在属水平上显著提高了Angelakisella和Ruminiclostridium 5等潜在有益菌的相对丰度,在操作分类单元水平上显著提高了Erysipelotrichaceae bacterium NYU-BL-F16等的相对丰度。肠道菌群互作网络和关联性分析结果表明,益生元组合干预富集的肠道菌与免疫炎症因子的改变显著相关。综上,混合益生元显示出更好的AD缓解效果,即实现了协同增效,有助于通过改变肠道微生物群结构组成和调节免疫反应来缓解AD,为开发改善AD的新策略提供了充足的科学依据。

本文引用格式

喻喜华 , 王一 , 李刘若兰 , 陈喜生 , 王宁 , 王鸿超 . 复合益生元组合缓解小鼠特应性皮炎并恢复肠道菌群失调[J]. 食品与发酵工业, 2026 , 52(5) : 101 -110 . DOI: 10.13995/j.cnki.11-1802/ts.042691

Abstract

Atopic dermatitis (AD) is a type of allergic skin disorder with high occurrence frequency.In this study, multiple prebiotics with immunomodulatory properties, including fructooligosaccharides (FOS), galactooligosaccharides (GOS), xylooligosaccharides (XOS), and inulin were selected based on literature review, aiming to investigate alleviation effects of individual prebiotics and their mixture on AD symptoms.The results indicated that prebiotic intervention alleviated pathological symptoms of skin in AD mice, accompanied by reduced infiltration of allergy-associated cells, decreased levels of immunoglobulin E (IgE) in serum and inflammatory cytokines, i.e. IL-4, IL-5, IL-13, and thymic stromal lymphopoietin (TSLP) in skin tissue, along with increased levels of IFN-γ in skin tissue.Among all groups, the mixture of four prebiotics demonstrated more efficient alleviation compared to individual prebiotic components.Sequencing analysis on gut microbiota revealed that the prebiotic mixture significantly regulated community structure, increased α-diversity, markedly elevated the relative abundance of potential beneficial genera (e.g., Angelakisella and Ruminiclostridium 5), and enriched abundances of operational taxonomic units such as Erysipelotrichaceae bacterium NYU-BL-F16.Microbial interaction network and correlation analyses demonstrated that enriched gut bacteria in response to prebiotic mixture intervention were significantly associated with alterations in inflammatory-associated indexes.Collectively, the prebiotic mixture exhibited more efficient mitigation against AD, achieving synergistic effects, which would contribute to AD alleviation via routes of regulating gut microbiota and modulating immune aspects of host, and provide scientific basis for development of novel intervention strategy against AD.

参考文献

[1] SCHULER C F, TSOI L C, BILLI A C, et al.Genetic and immunological pathogenesis of atopic dermatitis[J].Journal of Investigative Dermatology, 2024, 144(5):954-968.
[2] ZHOU Y G, ZHOU Y, ZHANG S L, et al.Identification of novel hub genes and immune infiltration in atopic dermatitis using integrated bioinformatics analysis[J].Scientific Reports, 2024, 14:23054.
[3] MOHAMMAD S, KARIM M R, IQBAL S, et al.Atopic dermatitis:Pathophysiology, microbiota, and metabolome - A comprehensive review[J].Microbiological Research, 2024, 281:127595.
[4] ÖZDEMIR E, ÖKSÜZ L.Effect of Staphylococcus aureus colonization and immune defects on the pathogenesis of atopic dermatitis[J].Archives of Microbiology, 2024, 206(10):410.
[5] DING G A, YANG X Z, LI Y, et al.Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases[J].Molecular and Cellular Biochemistry, 2025, 480(4):1969-1981.
[6] D’AMELIO P, SASSI F.Gut microbiota, immune system, and bone[J].Calcified Tissue International, 2018, 102(4):415-425.
[7] CHEN J, YUE Y H, WANG L, et al.Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease[J].Scientific Reports, 2020, 10(1):14525.
[8] YAN X M, YAN J B, XIANG Q W, et al.Early-life gut microbiota in food allergic children and its impact on the development of allergic disease[J].Italian Journal of Pediatrics, 2023, 49(1):148.
[9] 邓梦路, 张婕, 盛文彬.肠道菌群在儿童过敏性疾病中的研究进展[J].临床儿科杂志, 2024, 42(8):741-746.
DENG M L, ZHANG J, SHENG W B.Research progress of gut microbiota in allergic diseases in children[J].Journal of Clinical Pediatrics, 2024, 42(8):741-746.
[10] DU B Q, SHAMA A, ZHANG Y, et al.Gut microbiota and plasma metabolites in pregnant mothers and infant atopic dermatitis:A multi-omics study[J].World Allergy Organization Journal, 2025, 18(1):101017.
[11] HOSKINSON C, DAI D L Y, DEL BEL K L, et al.Delayed gut microbiota maturation in the first year of life is a hallmark of pediatric allergic disease[J].Nature Communications, 2023, 14:4785.
[12] YOO S, JUNG S C, KWAK K, et al.The role of prebiotics in modulating gut microbiota:Implications for human health[J].International Journal of Molecular Sciences, 2024, 25(9):4834.
[13] ROBERFROID M, GIBSON G R, HOYLES L, et al.Prebiotic effects:Metabolic and health benefits[J].The British Journal of Nutrition, 2010, 104(Suppl 2):S1-S63.
[14] BOCK P M, MARTINS A F, SCHAAN B D.Understanding how pre- and probiotics affect the gut microbiome and metabolic health[J].American Journal of Physiology.Endocrinology and Metabolism, 2024, 327(1):E89-E102.
[15] KUMARI T, BAG K K, DAS A B, et al.Synergistic role of prebiotics and probiotics in gut microbiome health:Mechanisms and clinical applications[J].Food Bioengineering, 2024, 3(4):407-424.
[16] DE FREITAS PEDROSA L, DE VOS P, FABI J P.From structure to function:How prebiotic diversity shapes gut integrity and immune balance[J].Nutrients, 2024, 16(24):4286.
[17] ULLAH H, ARBAB S, TIAN Y L, et al.Crosstalk between gut microbiota and host immune system and its response to traumatic injury[J].Frontiers in Immunology, 2024, 15:1413485.
[18] 方志锋. 双歧杆菌缓解特应性皮炎的作用及机制研究[D].无锡:江南大学, 2020.
FANG Z F.The role and mechanism of Bifidobacterium in alleviating atopic dermatitis[D].Wuxi:Jiangnan University, 2020.
[19] PLUM T, FEYERABEND T B, RODEWALD H R.Beyond classical immunity:Mast cells as signal converters between tissues and neurons[J].Immunity, 2024, 57(12):2723-2736.
[20] KAWAKAMI T, ANDO T, KIMURA M, et al.Mast cells in atopic dermatitis[J].Current Opinion in Immunology, 2009, 21(6):666-678.
[21] HAIFER C, SAIKAL A, PARAMSOTHY R, et al.Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy[J].Gut, 2021, 70(11):2210-2211.
[22] XIAO Y C, XU W N, SU W R.NLRP3 inflammasome:A likely target for the treatment of allergic diseases[J].Clinical & Experimental Allergy, 2018, 48(9):1080-1091.
[23] STOWER H.Training neuropathology[J].Nature Medicine, 2018, 24(6):702.
[24] CHEN M Y, SU Q, SHI Y G.Molecular mechanism of IgE-mediated FcεRI activation[J].Nature, 2025, 637(8045):453-460.
[25] 孔羽薇, 姚志荣.特应性皮炎相关细胞因子的研究进展[J].临床儿科杂志, 2019, 37(2):148-152.
KONG Y W, YAO Z R.Research progress on cytokines in atopic dermatitis[J].Journal of Clinical Pediatrics, 2019, 37(2):148-152.
[26] 罗静英, 黎小东, 李振洁, 等.特异性免疫治疗对特应性皮炎患者血清IL-4、IFN-γ的影响[J].岭南皮肤性病科杂志, 2009, 16(6):372-374.
LUO J Y, LI X D, LI Z J, et al.Effects of specific immunotherapy on the cytokines in atopic dermatitis[J].Southern China Journal of Dermato-Venereology, 2009, 16(6):372-374.
[27] LUO J L, ZHU Z, ZHAI Y M, et al.The role of TSLP in atopic dermatitis:From pathogenetic molecule to therapeutical target[J].Mediators of Inflammation, 2023, 2023(1):7697699.
[28] 张琳, 徐加英, 石羽杰, 等.双歧杆菌BB-12及其免疫调节功能的研究进展[J].上海预防医学, 2020, 32(7):600-605.
ZHANG L, XU J Y, SHI Y J, et al.Research progress on Bifidobacterium BB-12 and human immune regulation[J].Shanghai Journal of Preventive Medicine, 2020, 32(7):600-605.
[29] QIU X X, MACCHIETTO M G, LIU X T, et al.Identification of gut microbiota and microbial metabolites regulated by an antimicrobial peptide lipocalin 2 in high fat diet-induced obesity[J].International Journal of Obesity, 2021, 45(1):143-154.
[30] THOMPSON R S, GAFFNEY M, HOPKINS S, et al.Ruminiclostridium 5, Parabacteroides distasonis, and bile acid profile are modulated by prebiotic diet and associate with facilitated sleep/clock realignment after chronic disruption of rhythms[J].Brain, Behavior, and Immunity, 2021, 97:150-166.
[31] MAO J Z, WANG D X, LONG J Y, et al.Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers[J].Journal for Immunotherapy of Cancer, 2021, 9(12):e003334.
[32] 秦孟春, 张玲芳, 胡顺安, 等.乳酸菌的抗食物过敏及免疫调节特性的研究进展[J].中国酿造, 2024, 43(6):14-20.
QIN M C, ZHANG L F, HU S A, et al.Research progress on anti-food allergy and immunomodulatory properties of lactic acid bacteria[J].China Brewing, 2024, 43(6):14-20.
[33] XIE J, TIAN S M, LIU J, et al.Combination therapy with indigo and indirubin for ulcerative colitis via reinforcing intestinal barrier function[J].Oxidative Medicine and Cellular Longevity, 2023, 2023(1):2894695.
[34] YANG Z X, ZHU J L, LU W W, et al.Integrating artificial intelligence in exploring multiscale gut microbiota and diet relations for health promotion:A comprehensive review[J].Food Bioscience, 2024, 61:104541.
文章导航

/

〈 〉